Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.

Source:http://linkedlifedata.com/resource/pubmed/id/19535640

J. Immunol. 2009 Jul 1 183 1 749-58

Download in:

View as

General Info

PMID
19535640